363 related articles for article (PubMed ID: 33841389)
1. Validation of Differentially Expressed Immune Biomarkers in Latent and Active Tuberculosis by Real-Time PCR.
Perumal P; Abdullatif MB; Garlant HN; Honeyborne I; Lipman M; McHugh TD; Southern J; Breen R; Santis G; Ellappan K; Kumar SV; Belgode H; Abubakar I; Sinha S; Vasan SS; Joseph N; Kempsell KE
Front Immunol; 2020; 11():612564. PubMed ID: 33841389
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Host Protein Biomarkers by ELISA From Whole Lysed Peripheral Blood for Development of Diagnostic Tests for Active Tuberculosis.
Garlant HN; Ellappan K; Hewitt M; Perumal P; Pekeleke S; Wand N; Southern J; Kumar SV; Belgode H; Abubakar I; Sinha S; Vasan S; Joseph NM; Kempsell KE
Front Immunol; 2022; 13():854327. PubMed ID: 35720382
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional Profiling of Human Peripheral Blood Mononuclear Cells Identifies Diagnostic Biomarkers That Distinguish Active and Latent Tuberculosis.
Wang S; He L; Wu J; Zhou Z; Gao Y; Chen J; Shao L; Zhang Y; Zhang W
Front Immunol; 2019; 10():2948. PubMed ID: 31921195
[No Abstract] [Full Text] [Related]
4. Latent Tuberculosis Infection Diagnosis among Household Contacts in a High Tuberculosis-Burden Area: a Comparison between Transcript Signature and Interferon Gamma Release Assay.
Kaul S; Nair V; Birla S; Dhawan S; Rathore S; Khanna V; Lohiya S; Ali S; Mannan S; Rade K; Malhotra P; Gupta D; Khanna A; Mohmmed A
Microbiol Spectr; 2022 Apr; 10(2):e0244521. PubMed ID: 35416716
[TBL] [Abstract][Full Text] [Related]
5. Combination of HLA-DR on
Luo Y; Xue Y; Tang G; Lin Q; Song H; Liu W; Yin B; Huang J; Wei W; Mao L; Wang F; Sun Z
Front Immunol; 2021; 12():761209. PubMed ID: 34858413
[TBL] [Abstract][Full Text] [Related]
6. Differential Expression of Activation Markers by Mycobacterium tuberculosis-specific CD4+ T Cell Distinguishes Extrapulmonary From Pulmonary Tuberculosis and Latent Infection.
Silveira-Mattos PS; Barreto-Duarte B; Vasconcelos B; Fukutani KF; Vinhaes CL; Oliveira-De-Souza D; Ibegbu CC; Figueiredo MC; Sterling TR; Rengarajan J; Andrade BB
Clin Infect Dis; 2020 Nov; 71(8):1905-1911. PubMed ID: 31665254
[TBL] [Abstract][Full Text] [Related]
7. Host-response-based gene signatures for tuberculosis diagnosis: A systematic comparison of 16 signatures.
Warsinske H; Vashisht R; Khatri P
PLoS Med; 2019 Apr; 16(4):e1002786. PubMed ID: 31013272
[TBL] [Abstract][Full Text] [Related]
8. Multiple cytokine responses in discriminating between active tuberculosis and latent tuberculosis infection.
Wu J; Wang S; Lu C; Shao L; Gao Y; Zhou Z; Huang H; Zhang Y; Zhang W
Tuberculosis (Edinb); 2017 Jan; 102():68-75. PubMed ID: 28061954
[TBL] [Abstract][Full Text] [Related]
9. Activation Phenotype of
Luo Y; Xue Y; Mao L; Lin Q; Tang G; Song H; Liu W; Tong S; Hou H; Huang M; Ouyang R; Wang F; Sun Z
Front Immunol; 2021; 12():721013. PubMed ID: 34512645
[TBL] [Abstract][Full Text] [Related]
10. Relationship between DNA Methylation Profiles and Active Tuberculosis Development from Latent Infection: a Pilot Study in Nested Case-Control Design.
Du Y; Gao X; Yan J; Zhang H; Cao X; Feng B; He Y; He Y; Guo T; Xin H; Gao L
Microbiol Spectr; 2022 Jun; 10(3):e0058622. PubMed ID: 35446152
[TBL] [Abstract][Full Text] [Related]
11. Accurate diagnosis of latent tuberculosis in children, people who are immunocompromised or at risk from immunosuppression and recent arrivals from countries with a high incidence of tuberculosis: systematic review and economic evaluation.
Auguste P; Tsertsvadze A; Pink J; Court R; Seedat F; Gurung T; Freeman K; Taylor-Phillips S; Walker C; Madan J; Kandala NB; Clarke A; Sutcliffe P
Health Technol Assess; 2016 May; 20(38):1-678. PubMed ID: 27220068
[TBL] [Abstract][Full Text] [Related]
12. Predicting the Progress of Tuberculosis by Inflammatory Response-Related Genes Based on Multiple Machine Learning Comprehensive Analysis.
Ma S; Peng P; Duan Z; Fan Y; Li X
J Immunol Res; 2023; 2023():7829286. PubMed ID: 37228444
[TBL] [Abstract][Full Text] [Related]
13. Protein and Microbial Biomarkers in Sputum Discern Acute and Latent Tuberculosis in Investigation of Pastoral Ethiopian Cohort.
HaileMariam M; Yu Y; Singh H; Teklu T; Wondale B; Worku A; Zewude A; Mounaud S; Tsitrin T; Legesse M; Gobena A; Pieper R
Front Cell Infect Microbiol; 2021; 11():595554. PubMed ID: 34150670
[TBL] [Abstract][Full Text] [Related]
14. Identification of unique key genes and miRNAs in latent tuberculosis infection by network analysis.
Lin Y; Zhang Y; Yu H; Tian R; Wang G; Li F
Mol Immunol; 2019 Aug; 112():103-114. PubMed ID: 31082644
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional Profiling and Deriving a Seven-Gene Signature That Discriminates Active and Latent Tuberculosis: An Integrative Bioinformatics Approach.
Natarajan S; Ranganathan M; Hanna LE; Tripathy S
Genes (Basel); 2022 Mar; 13(4):. PubMed ID: 35456421
[TBL] [Abstract][Full Text] [Related]
16. Novel serological biomarker panel using protein microarray can distinguish active TB from latent TB infection.
Li J; Wang Y; Yan L; Zhang C; He Y; Zou J; Zhou Y; Zhong C; Zhang X
Microbes Infect; 2022; 24(8):105002. PubMed ID: 35598729
[TBL] [Abstract][Full Text] [Related]
17. Two interferon gamma release assays for predicting active tuberculosis: the UK PREDICT TB prognostic test study.
Abubakar I; Lalvani A; Southern J; Sitch A; Jackson C; Onyimadu O; Lipman M; Deeks JJ; Griffiths C; Bothamley G; Kon OM; Hayward A; Lord J; Drobniewski F
Health Technol Assess; 2018 Oct; 22(56):1-96. PubMed ID: 30334521
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic accuracy of interferon (IFN)-γ inducible protein 10 (IP-10) as a biomarker for the discrimination of active and latent tuberculosis.
Mamishi S; Mahmoudi S; Banar M; Hosseinpour Sadeghi R; Marjani M; Pourakbari B
Mol Biol Rep; 2019 Dec; 46(6):6263-6269. PubMed ID: 31564016
[TBL] [Abstract][Full Text] [Related]
19. Heme oxygenase-1 and neopterin plasma/serum levels and their role in diagnosing active and latent TB among HIV/TB co-infected patients: a cross sectional study.
Uwimaana E; Bagaya BS; Castelnuovo B; Kateete DP; Godwin A; Kiwanuka N; Whalen CC; Joloba ML
BMC Infect Dis; 2021 Jul; 21(1):711. PubMed ID: 34315412
[TBL] [Abstract][Full Text] [Related]
20. QuantiFERON-TB Gold Plus combined with HBHA-Induced IFN-γ release assay improves the accuracy of identifying tuberculosis disease status.
Tang J; Huang Y; Jiang S; Huang F; Ma T; Qi Y; Ma Y
Tuberculosis (Edinb); 2020 Sep; 124():101966. PubMed ID: 32866942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
